Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
3.080
+0.070 (2.33%)
At close: Feb 21, 2025, 4:00 PM
3.090
+0.010 (0.32%)
After-hours: Feb 21, 2025, 7:32 PM EST
Pliant Therapeutics Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Pliant Therapeutics stock have an average target of 14.86, with a low estimate of 4.00 and a high estimate of 45. The average target predicts an increase of 382.47% from the current stock price of 3.08.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Pliant Therapeutics stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 | 1 |
Buy | 4 | 4 | 4 | 4 | 4 | 3 |
Hold | 0 | 0 | 0 | 0 | 0 | 6 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 7 | 7 | 7 | 7 | 7 | 10 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 14, 2025 |
Needham | Needham | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +224.68% | Feb 14, 2025 |
JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 10, 2025 |
RBC Capital | RBC Capital | Buy → Hold Downgrades $45 → $4 | Buy → Hold | Downgrades | $45 → $4 | +29.87% | Feb 10, 2025 |
Canaccord Genuity | Canaccord Genuity | Strong Buy → Hold Downgrades $4 | Strong Buy → Hold | Downgrades | $4 | +29.87% | Feb 10, 2025 |
Financial Forecast
Revenue This Year
n/a
from 1.58M
Revenue Next Year
1.39M
EPS This Year
-3.71
from -2.75
EPS Next Year
-3.82
from -3.71
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | n/a | 15.8M | 21.0M | |||
Avg | n/a | 1.4M | 2.0M | |||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | 1,409.7% | |||
Avg | - | - | 46.7% | |||
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -3.75 | -1.86 | -1.12 | |||
Avg | -3.71 | -3.82 | -3.71 | |||
Low | -3.61 | -5.13 | -5.93 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.